Citadel Advisors’s Spruce Biosciences, Inc. Common Stock SPRB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-77,053
| Closed | -$36.6K | – | 6988 |
|
|
2024
Q3 | $36.6K | Sell |
77,053
-7,662
| -9% | -$3.64K | ﹤0.01% | 5195 |
|
|
2024
Q2 | $43.9K | Sell |
84,715
-3,162
| -4% | -$1.64K | ﹤0.01% | 5219 |
|
|
2024
Q1 | $69.1K | Sell |
87,877
-20,363
| -19% | -$16K | ﹤0.01% | 5214 |
|
|
2023
Q4 | $317K | Buy |
108,240
+33,210
| +44% | +$97.3K | ﹤0.01% | 4198 |
|
|
2023
Q3 | $170K | Buy |
75,030
+3,753
| +5% | +$8.48K | ﹤0.01% | 4623 |
|
|
2023
Q2 | $153K | Sell |
71,277
-1,627,341
| -96% | -$3.5M | ﹤0.01% | 4566 |
|
|
2023
Q1 | $3.75M | Sell |
1,698,618
-48,773
| -3% | -$108K | ﹤0.01% | 2035 |
|
|
2022
Q4 | $1.92M | Buy |
1,747,391
+17,848
| +1% | +$19.6K | ﹤0.01% | 2609 |
|
|
2022
Q3 | $2.37M | Buy |
1,729,543
+5,090
| +0.3% | +$6.97K | ﹤0.01% | 2571 |
|
|
2022
Q2 | $3M | Buy |
1,724,453
+2,607
| +0.2% | +$4.54K | ﹤0.01% | 2349 |
|
|
2022
Q1 | $3.46M | Sell |
1,721,846
-5,255
| -0.3% | -$10.6K | ﹤0.01% | 2409 |
|
|
2021
Q4 | $7.7M | Buy |
1,727,101
+26,025
| +2% | +$116K | ﹤0.01% | 1710 |
|
|
2021
Q3 | $10.2M | Sell |
1,701,076
-1,938
| -0.1% | -$11.6K | ﹤0.01% | 1421 |
|
|
2021
Q2 | $19.1M | Buy |
1,703,014
+209
| +0% | +$2.34K | ﹤0.01% | 991 |
|
|
2021
Q1 | $28.3M | Buy |
1,702,805
+1,018
| +0.1% | +$16.9K | 0.01% | 750 |
|
|
2020
Q4 | $41.4M | Buy |
+1,701,787
| New | +$41.4M | 0.01% | 512 |
|